GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
NCT05356104
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
110
Enrollment
OTHER
Sponsor class
Conditions
Cerebral Small Vessel Disease
Interventions
DRUG:
Exenatide extended release
Sponsor
Chinese University of Hong Kong